Persistence of tolerance to methamphetamine-induced monoamine deficits

European Journal of Pharmacology

Volumn 559, Issue 1, 2007, Pages 46-54

  Danaceau, Jonathan P ^a   Deering, Cassandra E ^a   Day, Jayme E ^a   Smeal, Stacy J ^a   Johnson Davis, Kamisha L ^b   Fleckenstein, Annette E ^a   Wilkins, Diana G ^a  

^a UNIVERSITY OF UTAH   (United States)

^b ARUP LABORATORIES   (United States)

Author keywords

Dopamine; Hyperthermia; Methamphetamine; Neurotoxicity; Persistence; Tolerance

Indexed keywords

METHAMPHETAMINE; MONOAMINE; TRYPTOPHAN HYDROXYLASE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG DOSE ESCALATION; DRUG MEGADOSE; DRUG TOLERANCE; FRONTAL CORTEX; HIPPOCAMPUS; HYPERTHERMIA; MALE; MONOAMINERGIC NERVE; NERVE ENDING; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

AMPHETAMINES; ANIMALS; BIOGENIC MONOAMINES; BODY TEMPERATURE; BRAIN CHEMISTRY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHROMATOGRAPHY, LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; MALE; MASS SPECTROMETRY; METHAMPHETAMINE; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33847023150     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.11.045     Document Type: Article

References (35)

1. Abekawa T., Ohmori T., and Koyama T. Tolerance to the neurotoxic effect of methamphetamine in rats behaviorally sensitized to methamphetamine or amphetamine. Brain Res. 767 (1997) 34-44
2. Albers D.S., and Sonsalla P.K. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. J. Pharmacol. Exp. Ther. 275 (1995) 1104-1114
3. Alburges M.E., Hanson G.R., and Gibb J.W. Role of methamphetamine metabolism in the development of CNS tolerance to the drug. Invest. Clin. 31 (1990) 165-176
4. Bell D.S. The experimental reproduction of amphetamine psychosis. Arch. Gen. Psychiatry 29 (1973) 35-40
5. Bowyer J.F., Davies D.L., Schmued L., Broening H.W., Newport G.D., Slikker W., and Holson R.R. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J. Pharmacol. Exp. Ther. 268 (1994) 1571-1180
6. Brown J., and Yamamoto B. Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress. Pharmacol. Ther. 99 (2003) 45-53
7. Cadet J.L., Jayanthi S., and Deng X. Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis. FASEB J. 17 (2003) 1775-1788
8. Chapin D.S., Lookingland K.J., and Moore K.E. Effects of LC mobile phase composition retention times for biogenic amines and their precursors and metabolites. Curr. Sep. 7 (1986) 68-70
9. Cho A.K., and Melega W.P. Patterns of methamphetamine abuse and their consequences. J. Addict. Dis. 21 (2002) 21-34
10. Davidson C., Gow A.J., Lee T.H., and Ellinwood E.H. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res. 36 (2001) 1-22
11. Fleckenstein A.E., Wilkins D.G., Gibb J.W., and Hanson G.R. Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine injection. J. Pharmacol. Exp. Ther. 283 (1997) 281-285
12. Fleckenstein A.E., Gibb J.W., and Hanson G.R. Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity. Eur. J. Pharmacol. 406 (2000) 1-13
13. Galai N., Safaeian M., Vlahov D., Bolotin A., and Celentano D.D. Longitudinal patterns of drug injection behavior in the ALIVE study cohort, 1998-2000: descriptions and determinants. Am. J. Epidemiol. 158 (2003) 695-704
14. Gibb J.W., Hanson G.R., and Johnson M. Neurochemical mechanisms of toxicity. In: Cho A.K., and Segal D.S. (Eds). Amphetamine and its Analogues (1994), Academic Press, San Diego, CA 269-295
15. Giovanni A., Liang L.P., Hastings T.G., and Zigmond M.J. Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J. Neurochem. 64 (1995) 1819-1825
16. Gygi M.P., Gygi S.P., Johnson M., Wilkins D.G., Gibb J.W., and Hanson G.R. Mechanisms for tolerance to methamphetamine effects. Neuropharmacology 35 (1996) 751-757
17. Imam S.Z., and Ali S.F. Aging increases the susceptibility to methamphetamine-induced dopaminergic neurotoxicity in rats: correlation with peroxynitrite production and hyperthermia. Neurochemistry 78 (2001) 952-959
18. Johnson-Davis K.L., Fleckenstein A.E., and Wilkins D.G. The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine toxicity. Eur. J. Pharmacol. 482 (2003) 283-289
19. Johnson-Davis K.L., Truong J.G., Fleckenstein A.E., and Wilkins D.G. Alterations in vesicular dopamine uptake contribute to tolerance to the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther. 309 (2004) 578-586
20. Kita T., Wagner G.C., and Nakashima T. Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption. J. Pharmacol. Sci. 92 (2003) 178-195
21. Lowry O.H., Rosenbrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
22. Melega W.P., Williams A.E., Schmitz D.A., Distefano E.W., and Cho A.K. Pharmacokinetics and pharmacodynamic analysis of the actions of d-amphetamine on the dopamine terminal. J. Pharmacol. Exp. Ther. 274 (1995) 90-96
23. Metzger R.R., Haughey H.M., Wilkins D.G., Gibb J.W., Hanson G.R., and Fleckenstein A.E. Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia. J. Pharmacol. Exp. Ther. 295 (2000) 1077-1085
24. NIDA. NIDA Research Report - Methamphetamine Abuse and Addiction (2002), National Institute on Drug Abuse 1-8
25. Poulos C.X., Hinson R.E., and Siegel S. The role of pavlovian processes in drug tolerance and dependence: implications for treatment. Addict. Behav. 6 (1981) 205-211
26. Riddle E.L., Kokoshka J.M., Wilkins D.G., Hanson G.R., and Fleckenstein A.E. Tolerance to the neurotoxic effects of methamphetamine in young rats. Eur. J. Pharmacol. 435 (2002) 181-185
27. Riviere G.J., Gentry W.B., and Owens S.M. Disposition of methamphetamine and its metabolite amphetamine in brain and other tissues in rats after intravenous administration. J. Pharmacol. Exp. Ther. 292 (2000) 1042-1047
28. Schmidt C.J., Gehlert M.A., Peat M.A., Sonsalla P.K., Hanson G.R., Wamsley J.K., and Gibb J.W. Studies on the mechanism of tolerance to methamphetamine. Brain Res. 343 (1985) 305-313
29. Schmidt C.J., Sonsalla P.K., Hanson G.R., Peat M.A., and Gibb J.W. Methamphetamine-induced depression of monoamine synthesis in the rat: development of tolerance. J. Neurochem. 44 (1985) 852-855
30. Self D.W. The neurobiology of relapse. In: Karch S.B. (Ed). Drug Abuse Handbook (1997), CRC Press, New York 442-463
31. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., and Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150 (1985) 76-85
32. Solomon R.L. The opponent-process theory of acquired motivation. Am. Psychol. 35 (1980) 691-712
33. Solomon R.L., and Corbit J.D. An opponent-process theory of motivation: I. Temporal dynamics of affect. Psychol. Rev. 81 (1974) 119-145
34. Stephans S., and Yamamoto B. Methamphetamine pretreatment and the vulnerability of the striatum to methamphetamine neurotoxicity. Neuroscience 72 (1996) 593-600
35. Thomas D.M., and Kuhn D.M. Attenuated microglial activation mediates tolerance to the neurotoxic effects of methamphetamine. J. Neurochem. 92 (2005) 790-797